Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medinotec (MDNC) Shares Outstanding (Weighted Average) (2022 - 2025)

Medinotec filings provide 4 years of Shares Outstanding (Weighted Average) readings, the most recent being $11.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.19% to $11.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was $11.8 million, a 0.19% change, with the full-year FY2025 number at $11.7 million, changed 0.0% from a year prior.
  • Shares Outstanding (Weighted Average) hit $11.8 million in Q4 2025 for Medinotec, roughly flat from $11.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $11.8 million in Q3 2025 to a low of $10.0 million in Q1 2022.
  • Median Shares Outstanding (Weighted Average) over the past 4 years was $11.7 million (2022), compared with a mean of $11.6 million.
  • The widest YoY moves for Shares Outstanding (Weighted Average): up 17.34% in 2023, down 0.0% in 2023.
  • Medinotec's Shares Outstanding (Weighted Average) stood at $11.7 million in 2022, then changed by 0.0% to $11.7 million in 2023, then changed by 0.0% to $11.7 million in 2024, then rose by 0.19% to $11.8 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $11.8 million (Q4 2025), $11.8 million (Q3 2025), and $11.7 million (Q2 2025) per Business Quant data.